The liver is involved in the regulation of serum levels of IgA through the selective transport and catabolism of circulating IgA, and in the removal of IgA-containing immune complexes. At least two types of receptors on hepatocytes are involved in these processes: secretory component (SC) which binds polymeric IgA and mediates its selective transport into the bile by a nondegradative pathway, and asialoglycoprotein receptor (ASGR) which directs bound ligands into the degradative pathway. The objective of this proposal is to investigate the role of the liver in IgA- and asialoglycoprotein-directed selective delivery and elimination of biologically active substances, and in the generation of immune responses at mucosal surfaces. The degradation and elimination of model toxins of plant and bacterial origins coupled with monoclonal antibodies of IgA or IgG isotypes, or with asialoglycoprotein, will be studied in both in vitro and in vivo systems. The biological consequences of the administration of free versus IgA antibody-, or asialoglycoprotein- complexed toxins will be compared. Furthermore, free and IgA- or asialoglycoprotein-linked interferon inducers will be evaluated with respect to their ability to induce interferon production in vitro and in vivo. Finally, the role of the liver in the induction of immune responses in external secretions will be investigated. Because of its central position, as the liver is most likely to be stimulated by antigens absorbed from the large surface area of the gut, and specific antibody-producing cells have been detected first in this organ. We will investigate whether the liver is an integral part of the common mucosal immune system, or whether it is an enriched reservoir of specific IgA antibody-forming cells ultimately destined for homing to other mucosal tissues. Furthermore, the origin of specific IgA antibodies in human hepatic bile will be determine by comparative studies of molecular properties and antigen specificities of IgA antibodies in human bile, serum, and saliva. The versatility of the liver in disposing of environmental substances is manifested by its apparent ability to focus cells that produce antibodies to antigens encountered at the large gastrointestinal surface, at the site where their effectiveness may be maximally utilized.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK028537-09
Application #
3228882
Study Section
Pathology B Study Section (PTHB)
Project Start
1982-01-01
Project End
1990-12-31
Budget Start
1990-01-01
Budget End
1990-12-31
Support Year
9
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
Schools of Dentistry
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Renegar, K B; Jackson, G D; Mestecky, J (1998) In vitro comparison of the biologic activities of monoclonal monomeric IgA, polymeric IgA, and secretory IgA. J Immunol 160:1219-23
Tomana, M; Matousovic, K; Julian, B A et al. (1997) Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int 52:509-16
Endo, T; Radl, J; Mestecky, J (1997) Structural differences among serum IgA proteins of chimpanzee, rhesus monkey and rat origin. Mol Immunol 34:557-65
Takahashi, T; Iwase, T; Takenouchi, N et al. (1996) The joining (J) chain is present in invertebrates that do not express immunoglobulins. Proc Natl Acad Sci U S A 93:1886-91
Mestecky, J; Hashim, O H; Tomana, M (1995) Alterations in the IgA carbohydrate chains influence the cellular distribution of IgA1. Contrib Nephrol 111:66-71;discussion 71-2
Wu, H Y; White, P L; Beagley, K W et al. (1995) IgA production and transport in the murine liver after mucosal immunization. Adv Exp Med Biol 371B:1061-6
Tomana, M; Julian, B A; Waldo, F B et al. (1995) IgA nephropathy. A disease of incomplete IgA 1 glycosylation? Adv Exp Med Biol 376:221
Stenberg, L; O'Toole, P W; Mestecky, J et al. (1994) Molecular characterization of protein Sir, a streptococcal cell surface protein that binds both immunoglobulin A and immunoglobulin G. J Biol Chem 269:13458-64
Nikolova, E B; Tomana, M; Russell, M W (1994) The role of the carbohydrate chains in complement (C3) fixation by solid-phase-bound human IgA. Immunology 82:321-7
Wold, A E; Motas, C; Svanborg, C et al. (1994) Lectin receptors on IgA isotypes. Scand J Immunol 39:195-201

Showing the most recent 10 out of 29 publications